The General Population Cohort (GPC) was set up in 1989 to examine trends in HIV prevalence and incidence, and their determinants in rural south-western Uganda. Recently, the research questions have included the epidemiology and genetics of communicable and non-communicable diseases (NCDs) to address the limited data on the burden and risk factors for NCDs in sub-Saharan Africa. The cohort comprises all residents (52% aged 513years, men and women in equal proportions) within one-half of a rural sub-county, residing in scattered houses, and largely farmers of three major ethnic groups. Data collected through annual surveys include; mapping for spatial analysis and participant location; census for individual socio-demographic and household socioeconomic status assessment; and a medical survey for health, lifestyle and biophysical and blood measurements to ascertain disease outcomes and risk factors for selected participants. This cohort offers a rich platform to investigate the interplay between communicable diseases and NCDs. There is robust infrastructure for data management, sample processing and storage, and diverse expertise in epidemiology, social and basic sciences.
Data Resource basics
Rationale, collaborations and funding The General Population Cohort (GPC) is a populationbased open cohort study established in 1989 by the Medical Research Council (MRC) UK in collaboration with the Uganda Virus Research Institute (UVRI) to examine trends in prevalence and incidence of HIV infection and their determinants. This cohort is funded by MRC UK and the UK Department for International Development.
Since 2010, the scientific research questions have incorporated the epidemiology and genetics of both communicable and non-communicable diseases (NCDs). Although NCDs are projected to become the most common causes of death in Africa by 2030, 1 their magnitude, distribution and risk factors have not been fully studied in a large-scale epidemiological context in sub-Saharan Africa. The GPC provides a unique framework for building on a large-scale prospective cohort study in a sub-Saharan African population to examine a wide range of health indices. This provides the foundation for long-term studies providing evidence for health policy and public health programmes in Uganda and other countries in subSaharan Africa. Observational studies suggest that infectious diseases such as HIV and tuberculosis may be risk factors for type 2 diabetes. 2 The collaboration with the University of Cambridge and the Wellcome Trust Sanger Institute has strengthened the GPC platform and enabled both NCDs and infectious diseases to be studied in parallel, improving efficiency while allowing investigation of reciprocal relationships between communicable and noncommunicable diseases.
Genetic studies
The introduction of genetic studies into the GPC was driven by the dearth of genetic epidemiological studies in sub-Saharan African populations. Most of the studies have focused on populations of European descent. [3] [4] [5] To generalize findings from genetic studies of complex diseases it is important to examine genetic susceptibility in a global context, with studies in sub-Saharan African populations, where genetic diversity is greatest, 6, 7 forming an integral component of this effort. The complex patterns of genetic diversity and gene expression in modern human populations are the result of varying evolutionary histories shaped by differing environmental and biological factors. 8, 9 This diversity might account for some differences in the prevalence of complex diseases and distribution of risk factor traits among populations. 10, 11 Genetic analysis has the potential to: discover novel disease susceptibility loci and variants; assess the structure of association signals; and refine (fine-map) association signals at new and existing disease and trait loci. 12 
Data Resource area and population coverage
The study area is located in south-western Uganda in Kyamulibwa sub-county of Kalungu district, approximately 120 km from Entebbe town (where the MRC/ UVRI office and central laboratories are located). The study area is divided into villages defined by administrative boundaries varying in size from 300 to 1500 residents. From 1989-99, the initial study population of about 10 000 residents comprised a cluster of 15 neighbouring villages and a pilot village for pretesting study tools and procedures. From 1999, ten more adjacent villages with comparable characteristics, 13 were added to the cohort, doubling the population. At the centre of the study area (village 17; Figure 1 ) is the MRC/UVRI field station with administrative offices, laboratories and study clinics.
Survey frequency
The study population is recruited through annual house-to-house 'rounds' of census through which participants for the medical surveys are selected. To be eligible for the census, an individual must have spent or be planning to spend at least 3 months in a household within the study area. All residents aged 13 years and above were included in all the medical survey rounds 1-22 (1989-2011) . For the first seven medical survey rounds (1989-96) all residents (all ages) were eligible for the survey, although children under 13 years were only surveyed for de-worming in rounds 5-7 (1993-96) . In rounds 8-10 (1996-99) children under 13 years were excluded. From survey rounds 11-22 (1999-2011) all children aged 0-2 years were included in the medical survey but all the children aged 3-12 years were only surveyed in rounds 11(1999-2000) , 13 (2001-02), 16 (2004-05) , 19 (2007-08) , and 22 (2010-11) . In the rest of the rounds, only children aged 3-12 years exposed to maternal HIV infection or with previous positive HIV-tests or those missed in the previous round to be surveyed were included (Table 1 ). All these exclusions were driven by study themes and resources.
Demographic and social characteristics of the study population at round 22 (2010-11) show a relatively young population with about 90% of the population less than 50 years of age, predominantly engaged in subsistence farming. The major ethnic group are Baganda (75%), followed by immigrants from Rwanda (16%) and Burundi (3%) and other tribes from Uganda and Tanzania (6%) who initially came as casual labourers. Only about 13% of the residents attained education beyond primary level (not shown in tables).
Overall, over 95% of households approached for census participated. The medical survey participation varied from year to year. Participation for 13 medical survey rounds (1989-92, 1997-2002, 2003-05 and 2008-11) was consistently above 70% with the first two rounds and for the latest round above 80%. Participation in the rest of the rounds was above 60% (Table 1) .
Data from round 22 shows that the surveyed population of children aged 0-12 years was representative of those in the census (Table 2 ). Adult survey characteristics showed a higher participation of women than men, and of those ever married (currently married, widowed and separated) than never married. Children, siblings and grandchildren to the household head were underrepresented in the survey in comparison with the spouse and parent of the household head. As expected, those usually resident had better participation than those who spent less time in their households. The Baganda had a lower participation than the other ethnic groups in the study population. Religion had no influence on participation (Table 2) .
Measures
The recruitment and data collection process is broadly divided into five stages as outlined in Figure 2 .
Participant engagement and village mapping
Community mobilisation precedes the recruitment process and focuses on engaging with participants at both community and individual levels. Local leaders are first sensitised about study activities and their permission sought before holding community meetings. Community mobilisation is followed by mapping, then the census and medical survey. In 2008, hand-drawn maps were replaced by mapping using Geographical Positioning System (GPS) technology, precisely locating all dwellings and demarcating village boundaries and principal geographical features within the study area.
A census questionnaire is administered to a household head or adult representative to collect individual demographic and household socioeconomic data. For individuals who decline, reasons for non-participation are recorded. Where no respondent is available, three attempts are made to revisit the household.
Medical survey
Using the census database, eligible individuals are selected and requested to participate in the medical survey. Data on health and lifestyle are collected using a standard individual questionnaire, blood samples obtained and biophysical measurements taken, when necessary. In rounds 20 (2008-09) and 22 (2010-11) the original HIV risk questionnaire was adapted to obtain socio-demographic indices, sexual behaviour, lifestyle (diet, tobacco and alcohol consumption), medical history and biophysical measurements (height, weight, waist and hip circumferences and blood pressure) data in one interview session.
Blood samples are transported to MRC/UVRI laboratories in Entebbe. A portion of the venous blood sample is analysed according to protocol guidelines and the remaining portion is stored at -808C. Remnant cells from serum samples are also collected and stored to provide DNA for future genetic analyses. Serum samples from participants over the previous 22 years are currently in storage. Such bio-banking of samples is invaluable for longitudinal and retrospective analysis. Most tests are done at the MRC/UVRI Uganda laboratories except for genetic tests, including Survey rounds during which children (0-12yrs) were only included for de-worming. No other survey information is available for this age group in these rounds. b denotes number of children aged 3-12 years with either previous maternal HIV exposure, or HIV positive test in the previous round or those who were missed in the previous round survey. They were excluded in the total participation because their denominator could not easily be estimated. Clinical follow-up and care: integration and technology A clinic located at the field station provides general health care to all study participants who present with acute medical conditions (malaria and acute respiratory tract infections among others) and chronic diseases such as HIV, hepatitis B and C, hypertension, diabetes and dyslipidaemia identified during medical surveys. The same participant identification numbers used in the census and survey are maintained in the clinic e-database making it possible to link these data to the survey data sets. When needed, clinicians can access previous clinical records and lifestyle and biophysical data collected during medical surveys to improve clinical assessments and medical decisions. The electronic system also ensures that data are organised and linked for research purposes. 
Ethical considerations

Data management and analysis
Households and individuals are assigned identification numbers during mapping and census. The GPS mapping data are downloaded onto a database and analysed using Arc-GIS software giving geographical and social details for spatial disease trends and risk analysis. Electronic data capture was introduced in 2009-10 to replace paper questionnaires. For the census and medical surveys, the pre-programmed e-questionnaire is prepared and loaded onto hand-held portable computers. The programme is linked to the central census database from previous rounds, allowing easy identification of participants. This ensures that data from previous rounds and between the census and survey are linked for each participant. The e-questionnaires for census and survey are also programmed to perform automatic data checks such as double entry of numbers, plausibility of answers (for instance 'age of starting to smoke cannot be older than age of participant'), numerical limitations within ranges of plausibility and automatic question skips based on previous answers. The immediate availability of electronic data, without the need for separate data entry, has greatly increased the efficiency and effectiveness of data cleaning, checking and management. The availability of the electronic clinic database also provides an opportunity to link these data with the survey data during analysis of risk factors or disease outcomes and directly assess the prevalence of clinical disease.
Data available
As shown in Table 3 , most of the survey rounds collected individual and household level demographic data, sexual behaviour and reproductive health. Limited data on NCD risk were collected in earlier survey rounds, smoking in rounds 5 and 21 and alcohol in rounds 8 and 12. Weight and height were measured annually in the first four rounds and round 6. In round 20, the following data were collected on NCD risk: weight, height, waist and hip circumference, blood pressure, blood glucose and smoking. During round 22 all the major modifiable cardiometabolic risk factors were assessed together with infectious biomarkers (HIV, hepatitis B and C) ( Table 3) .
Blood samples for DNA extractions are available for more than 8000 participants. To date, genotype data have been generated for more than 5000 participants using the Illumina HumanOmni2.5 BeadChip. These extensive genotype data combined with the NCD and additional health data collected from the participants constitute a unique resource to understand human genome diversity in sub-Saharan Africa and the aetiology of communicable and non-communicable diseases. Using the familial study design, up to 100 founders within each family have undergone whole genome sequencing. Additional whole genome sequencing studies are now under way.
Data resource use
The GPC has made substantial contributions on trends of HIV prevalence and incidence that have been used for planning national HIV/AIDS programmes in Uganda, and globally. As shown in Figure 3 , HIV prevalence decreased from 8.5% in 1991 to 6.1% in 2000 and remained fairly the same until 2005 when it steadily rose to 8.9% in 2010 in the presence of a steadily declining HIV incidence. This trend is attributable to better survival due to improvements in HIV care from the introduction of ART, as shown by a significant drop in death rates after introduction of ART in a recently published work from the same population. 15 . The recent Uganda AIDS indicator survey results showed a rise in HIV prevalence up from 6.4% in 2005 to 7.3% in 2011. 16 In the absence of national population-based mortality data in relation to ART, the GPC findings provide a possible reason for the rise in HIV prevalence.
The key findings of the GPC have been published as scientific papers (approximately 90 original articles between 1991 and 2012, most of which are available on the MRC/UVRI website: http://www.mrcuganda. org/Publications.html). Some of the key publications are as follows:
(i) Trends of HIV epidemic and risk factors in rural Uganda: changes in sexual behaviour and other risk factors shaping the epidemic in a rural African setting. [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] (ii) HIV-associated mortality: HIV-associated mortality in a rural population in Uganda, largely before the introduction of anti-retroviral therapy including the survival of children born to HIV-infected mothers. [36] [37] [38] [39] [40] [41] [42] (iii) HIV infection and effect on children in rural communities: the effects of HIV as seen in orphanhood and child nutrition. [43] [44] [45] [46] (iv) HIV infection and fertility: highlighting the impact of HIV infection on fertility. 47 (v) Sexually transmitted infections: prevalence and incidence of sexually transmitted infections in rural Uganda and the contribution of this to HIV infection. [48] [49] [50] (vi) Eye and dental problems: exploration of the occurrence of visual and dental problems in this rural population. [51] [52] [53] [54] [55] (vii) NCDs: epidemiology with specific emphasis on the prevalence of cardiovascular risk factors at population level has also been assessed. 56, 57 (viii) Social science contributions: in understanding the behavioural characteristics of the study population in relation to participation in research, 58, 59 HIV risks, 60-65 uptake of health services 66, 67 and impact of the epidemic on households and individuals. [68] [69] [70] (ix) Basic science: evaluation HIV testing algorithms, 71 HIV sub-type distribution and its relationship to HIV progression, [72] [73] [74] [75] [76] [77] and the association between hepatitis G and HIV infection. 78 (x) Methodological studies: evaluation of respondent-driven sampling in the GPC by comparing estimates from a respondent-driven sampling survey with total population data. [79] [80] [81] (xi) Older people studies: focusing on the health and functional status of older people affected by HIV. 82, 83 (xii) The involvement of the GPC in the ALPHA (Analysing Longitudinal Population-based HIV/AIDS data on Africa) network: has resulted in a considerable HIV epidemiological research output, both in terms of papers based on GPC data and collective ALPHA network papers which include GPC data. 84 (xiii) GPC contribution to international policy on NCDs: research in round 20 contributed to the development of international policy on NCD research.
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Main strengths and weaknesses A major strength of the GPC is conducting frequent census rounds and high participation especially for THE GENERAL POPULATION COHORT IN UGANDA Type of information  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22 Demographics Agethe census, which provides a relevant sampling frame for the survey and a database for imputing survey data for non-participants. A further strength is the availability of information at community, household and individual levels, providing a framework for multiple-level determinants of disease outcomes. Having no upper age limit for the survey provided an opportunity to study disease trends in a largely neglected older population. An additional strength of this cohort is the statistical power afforded by the large sample size, allowing us to explore multiple determinants of disease outcomes. The multidisciplinary approach, encompassing epidemiology and social and basic science, allows investigators to put together expert knowledge from their disciplines to provide a thorough and comprehensive analysis of the study outcomes. An equally important strength is the support of the community to the research activities in this area. This support has been achieved through continuous dialogue with the communities, resulting in a high level of trust and response to potentially sensitive questions. The research clinic established to meet the basic health care needs of the study participants provides an opportunity to merge clinic data with survey data to explore disease trends and possible interventions. The long experience of staff and the introduction in 2009 of electronic data capture has provided high quality data and research of an international standard in a resource-constrained context. A potential limitation of the GPC is that this population has, to some extent, been 'sensitised to epidemiological research', especially on HIV and sexuality, leading to refusals and influencing participant behaviour, in some cases. However, participation has been greatly improved with the change of focus to NCDs. Although only limited longitudinal data on NCDs has been collected in this cohort, there is a unique opportunity to use stored samples that could potentially provide important insights into NCDs and their risk factors and also chronic infection, including hepatitis virus infections. Being a relatively homogeneous rural sub-Saharan African population, genetic findings may not be generalisable to all populations in the region where there are multiple ethnic differences. This highlights the importance of conducting studies across sub-Saharan Africa to fully understand differences in chronic disease risk attributable to environmental and genetic determinants.
Data resource access
The GPC database is rich, with 22 years of longitudinal data sets on demographics and disease surveillance. All data (census, survey and laboratory) generated through the cohort are stored and curated at the MRC/UVRI Uganda Research Unit on AIDS. 
